BMRN vs TAOX · P/E 40, rev $1.76B vs rev $477.4K
Biomarin Pharmaceutical Inc (BMRN) versus TAO Synergies Inc. (TAOX) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
TAO Synergies Inc. (TAOX) is a software - infrastructure company listed on NASDAQ.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported TAOX revenue for 2026-06-30 was $477.4K. Net income was -$5.0M. Revenue was up 22.8% from 2026-03-31 to 2026-06-30. TAOX currently screens at market cap $30.2M.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. TAOX currently screens at market cap $30.2M.
Not investment advice. Open the BMRN and TAOX stock pages for the full models.
Not investment advice.